Press release
05.09.2025 To the attention of interested persons PRAC starts safety review of levamisole, a medicine used to treat parasitic worm […]
Press release
05.09.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September […]
Press release
03.09.2025 To the attention of interested persons Warning about sharp rise in illegal medicines sold in the EU download document […]
Press release
29.08.2025 To the attention of interested persons NAMMDR – Specifications on establishing the level of compensation of some medicinal products […]
Press release
26.08.2025 To the attention of interested persons Information regarding the misuse of the name of the National Agency for Medicines […]
Summary of field safety notifications / JULY 2025
SUMMARY OF FIELD SAFETY NOTIFICATIONS / JULY 2025 USER INFORMATION BIOFIRE® Blood Culture Identification 2 (BCID2) Panel / manufacturer BioFire […]
Press release
01.08.2025 To the attention of interested persons Rybelsus: Risk of medication error due to new tablet formulation download document …
Important notification
04.08.2025 To the attention of all interested parties The NAMMDR was informed about the presence on the territory of Portugal […]
Important notification
01.08.2025 To the attention of all interested persons The NAMMDR warns of the withdrawal of the EC certification for Los […]
Important notification
31.07.2025 To the attention of Romanian manufacturers of medical devices and in vitro diagnostic medical devices and all interested parties […]